CG Oncology, Inc. Common stockCGONNASDAQ
Loading
SG&A Expenses Over TimeExpanding
Percentile Rank100
3Y CAGR+125.6%
Studio
Year-over-Year Change

Selling, general, and administrative expenses

3Y CAGR
+125.6%/yr
Annual compound
Percentile
P100
Near historical high
vs 3Y Ago
11.5x
Strong expansion
Streak
4 yr
Consecutive growthExpanding
PeriodValueYoY Change
TTM$73.37M+117.7%
2024$33.70M+240.4%
2023$9.90M+54.9%
2022$6.39M+37.9%
2021$4.63M-